Comprehensive risk assessment for early neurologic complications after liver transplantation

Table 3 Comparison of variables from multiple perspectives between the neurologic complications and control groups

	NC	No NC	P value
	(n = 142)	(n =146)
Recipient variables
Preoperative
Age (yr)	51.75 ± 10.51	52.77 ± 9.09	0.567
Gender (M/F)	109/33	104/42	0.347
BMI (kg/m2)	24.65 ± 4.25	24.26 ± 3.11	0.617
Hepatitis B	86	89	1.000
Hepatitis C	30	43	0.136
Alcoholic liver disease	50	27	0.001
HCC	51	87	< 0.0001
Child-Pugh score	10.26 ± 2.26	8.27 ± 2.32	< 0.0001
MELD score	20.3 ± 9.4	14.0 ± 7.4	< 0.0001
Hepatic encephalopathy	91	41	< 0.0001
Variceal bleeding	51	63	0.229
Ascites	106	83	0.002
Mental disorder	66	33	< 0.0001
Serum Albumin (g/dL)	2.95 ± 0.57	3.21 ± 0.72	0.01
Serum T. bilirubin (mg/dL)	10.91 ± 13.16	4.74 ± 7.79	< 0.0001
Perioperative
Blood loss (mL)	3329 ± 3953	2474 ± 2728	0.081
Operation time (min)	558.98 ± 99.63	579.9 ± 127.0	0.160
Complex vascularity	45	30	0.033
Postoperative
Day 7 tacrolimus level (ng/mL)	8.23 ± 7.42	6.54 ± 4.69	0.023
Acute rejection	38	23	0.030
Intra-abdominal infection	32	12	< 0.0001
Kidney injury requiring dialysis	18	7	0.021
Donor variables
Donor age (yr)	32.5 ± 11.4	33.6 ± 11.0	0.234
Donor gender (M/F)	89/53	82/64	0.282
Graft type (whole/left/right/S67)	45/21/74/2	50/26/68/2	0.827
Donor-recipient matching
GRWR	1.33 ± 0.56	1.35 ± 0.57	0.726
Surgeon variables
Surgeon A/B/C	116/25/1	118/26/2	0.855
Sequence of transplantation	95.35 ± 69.66	108.12 ± 74.41	0.186

NCs: Neurologic complications; HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; GRWR: Graft-recipient weight ratio; BMI: Body mass index.